| 7.57 Delayed Data As of Nov 12 |  -0.22 / -2.82%Today’s Change | 3.32 Today|||52-Week Range 9.38 | +84.63% Year-to-Date |
| TG Therapeutics Inc (TGTX) Q3 2019 Earnings Call Transcript Nov 12 / MotleyFool.com - Paid Partner Content |
| Previous close | 7.79 |
| Today’s open | 7.55 |
| Day’s range | 7.31 - 7.91 |
| Volume | 1,387,493 |
| Average volume (3 months) | 1,153,732 |
| Market cap | $773.7M |
| Earnings growth (last year) | -20.36% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -0.25% |
| P/E ratio | NM |
| Price/Sales | 2,035.62 |
| Price/Book | 28.49 |
| Today’s change | Today’s % change | |
|---|---|---|
| HSKAHeska Corp | +2.84 | +3.18% |
| KURAKura Oncology Inc | +0.05 | +0.32% |
| TXMDTherapeuticsMD Inc | -0.12 | -4.21% |
| RVNCRevance Therapeutics... | +0.05 | +0.33% |
| Next reporting date | March 5, 2020 |
| EPS forecast (this quarter) | -$0.33 |
| Annual revenue (last year) | $152.0K |
| Annual profit (last year) | -$173.5M |
| Net profit margin | -114,132.89% |
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters New York, New York |
